Y.S.P. Southeast Asia Holding Bhd has a current ratio of 5.43. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.
The historical rank and industry rank for Y.S.P. Southeast Asia Holding Bhd's Current Ratio or its related term are showing as below:
XKLS:7178'
s Current Ratio Range Over the Past 10 Years
Min: 3.3 Med: 4.74 Max: 5.89
Current: 5.43
During the past 13 years, Y.S.P. Southeast Asia Holding Bhd's highest Current Ratio was 5.89. The lowest was 3.30. And the median was 4.74.
XKLS:7178's Current Ratio is ranked better than 87.96% of 997
companies
in the Drug Manufacturers industry
Industry Median: 2
vs XKLS:7178: 5.43
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Y.S.P. Southeast Asia Holding Bhd Current Ratio Related Terms
Y.S.P. Southeast Asia Holding Bhd Current Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Y.S.P. Southeast Asia Holding Bhd Current Ratio Chart
XKLS:7178 vs ZTS, UTHR, VTRS: Current Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Y.S.P. Southeast Asia Holding Bhd's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Y.S.P. Southeast Asia Holding Bhd Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Y.S.P. Southeast Asia Holding Bhd's Current Ratio distribution charts can be found below:
* The bar in red indicates where Y.S.P. Southeast Asia Holding Bhd's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) has a Current Ratio of 5.43 as of Mar. 2026. This is 15% above median its historical median of 4.74. Over the past decade, Y.S.P. Southeast Asia Holding Bhd's Current Ratio has ranged from 3.30 to 5.89. According to the industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #120 out of 997 companies in the Drug Manufacturers industry, placing it in the top 12%.
Is Y.S.P. Southeast Asia Holding Bhd's Current Ratio too high?
Y.S.P. Southeast Asia Holding Bhd's current Current Ratio of 5.43 is 15% above median its 10-year median of 4.74. Over the past 10 years, this metric has ranged from a low of 3.30 to a high of 5.89. The Drug Manufacturers industry median Current Ratio is 2.00. Y.S.P. Southeast Asia Holding Bhd's value of 5.43 is 171.5% above this industry median. Based on the distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #120 out of 997 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Y.S.P. Southeast Asia Holding Bhd has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Y.S.P. Southeast Asia Holding Bhd's Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Y.S.P. Southeast Asia Holding Bhd ranks #120 out of 997 companies for Current Ratio. This places Y.S.P. Southeast Asia Holding Bhd in the top 12% of its industry — outperforming the majority of peers. The industry median Current Ratio is 2.00. Y.S.P. Southeast Asia Holding Bhd's value of 5.43 is 171.5% above this benchmark. Historically, Y.S.P. Southeast Asia Holding Bhd's own Current Ratio has ranged from 3.30 to 5.89 over the past decade. While the company's 10-year median is 4.74 vs. the industry median of 2.00, Y.S.P. Southeast Asia Holding Bhd has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 997 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Y.S.P. Southeast Asia Holding Bhd's current Current Ratio of 5.43 is 171.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Y.S.P. Southeast Asia Holding Bhd's current Current Ratio is 5.43, which is 15% above median its own 10-year median of 4.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Y.S.P. Southeast Asia Holding Bhd stock overvalued right now?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) is currently considered Modestly Undervalued. The stock's GF Value™ is RM2.40, compared to a current price of RM2.02 — trading 15.8% below its estimated fair value. The current Current Ratio is 5.43, which is 15% above median its 10-year median of 4.74 and 171.5% above the Drug Manufacturers industry median of 2.00. Y.S.P. Southeast Asia Holding Bhd's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Y.S.P. Southeast Asia Holding Bhd (XKLS:7178), the current Current Ratio is 5.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Y.S.P. Southeast Asia Holding Bhd (XKLS:7178) Overvalued in 2026?
Based on GuruFocus' analysis, Y.S.P. Southeast Asia Holding Bhd stock appears to be undervalued.
The current stock price of RM2.02 is trading 15.8% below its estimated GF Value™ of RM2.40.
GuruFocus considers Y.S.P. Southeast Asia Holding Bhd to be Modestly Undervalued.
Key valuation signals for XKLS:7178:
Current Ratio: 5.43 (15% above median its 10-year median of 4.74)
GF Value™: RM2.40 vs. price of RM2.02 (15.8% below fair value)
Industry Position: 171.5% above the Drug Manufacturers median (#120 of 997)
No single metric tells the full story. See the XKLS:7178 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Y.S.P. Southeast Asia Holding Bhd Business Description
Y.S.P. Southeast Asia Holding Bhd is an investment company, that engages in the pharmaceutical business, and provision of management services. The company operates through the following segments: Trading, Manufacturing, and Investment Holding. The Trading segment imports, exports, and trading in various kinds of pharmaceutical products, and traditional herbal and veterinary products. The Manufacturing segment manufactures pharmaceutical products. The Investment Holding segment focuses on investment holding activity. The firm's majority of revenue comes from the Manufacturing segment. The majority of revenue is derived from Malaysia.
82GF Score
Get the complete analysis for XKLS:7178
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7178 has been successfully added to your 
